LEHI, Utah, Sept. 4, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class anti-inflammatory therapies, today announced that the Company plans to participate in the Morgan Stanley 23rd Annual Global Healthcare Conference.

Jared Bearss, Chief Operating Officer of Halia, will provide a business overview presentation on Tuesday, September 9, 2025 at 7:00 am ET.

About Halia Therapeutics

Halia Therapeutics is a clinical-stage biopharmaceutical company focused on treating the root causes of inflammation. Leveraging genetic insights and AI-enabled discovery, Halia is building a robust pipeline of novel therapeutics based on genetic resilience that targets inflammatory pathways in diseases ranging from metabolic disorders to neurodegeneration and hematologic malignancies.

Halia's mission is to create data-driven therapies that not only extend life but also improve its quality. The company is headquartered in Lehi, Utah, and is actively advancing global partnerships in clinical research, drug discovery, and personalized medicine.

To learn more, visit www.haliatx.com or follow us on LinkedIn and Twitter @HaliaTx.

Media Contact

Taylor Avei
Director of Business Development
Halia Therapeutics
info@haliatx.com

Investor Contact

Leigh Salvo
New Street Investor Relations
leigh@newstreetir.com

Logo - https://mma.prnewswire.com/media/2702932/Halia_Therapeutics_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/halia-therapeutics-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference-302546094.html

Images

Tags

More Like This

Halia Therapeutics Strengthens Global Genomics Leadership with Appointment of Paul Jones as Chief Strategy Officer & GM, International Markets

Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)

Hansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference

Tiziana Life Sciences to Present at the 37th Annual Roth Conference

Hansa Biopharma to Attend Truist Securities BioPharma Symposium

Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia

Tiziana Life Sciences to Present at the Bio International Convention